The Board of Directors of BrightGene Bio-Medical Technology Co., Ltd. has authorized a buyback plan on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.4 CNY | +1.56% | +10.12% | +9.71% |
07/05 | China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7% | MT |
07/05 | BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.71% | 2.21B | |
+37.93% | 705B | |
+32.82% | 583B | |
-3.76% | 364B | |
+19.79% | 332B | |
+5.00% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.88% | 169B |
- Stock Market
- Equities
- 688166 Stock
- News BrightGene Bio-Medical Technology Co., Ltd.
- BrightGene Bio-Medical Technology Co., Ltd. authorizes a Buyback Plan.